Montalescot G - Search Results

1

Antithrombotic Therapy After Transcatheter Aortic Valve Replacement.

Capodanno D, Collet JP, Dangas G, Montalescot G, Ten Berg JM, Windecker S, Angiolillo DJ. Capodanno D, et al. Among authors: montalescot g. JACC Cardiovasc Interv. 2021 Aug 9;14(15):1688-1703. doi: 10.1016/j.jcin.2021.06.020. JACC Cardiovasc Interv. 2021. PMID: 34353601 Free article. Review.

2

[Should all cases of aortic valve stenosis be surgically treated?].

Drobinski G, Montalescot G. Drobinski G, et al. Among authors: montalescot g. Ann Cardiol Angeiol (Paris). 1994 Nov;43(9):519-22. Ann Cardiol Angeiol (Paris). 1994. PMID: 7864556 French.

3

[New antithrombotic agents in coronary disease].

Montalescot G. Montalescot G. Rev Med Interne. 1997;18(6):450-9. doi: 10.1016/s0248-8663(97)80616-9. Rev Med Interne. 1997. PMID: 9247044 Review. French.

4

Fibrinogen as a risk factor for coronary heart disease.

Montalescot G, Collet JP, Choussat R, Thomas D. Montalescot G, et al. Eur Heart J. 1998 Jul;19 Suppl H:H11-7. Eur Heart J. 1998. PMID: 9717059 Review.

5

Pharmacological remodeling of the thrombus architecture.

Collet JP, Montalescot G, Soria J, Mishal Z, Soria C. Collet JP, et al. Among authors: montalescot g. Blood Coagul Fibrinolysis. 1999 Feb;10 Suppl 1:S49-53. Blood Coagul Fibrinolysis. 1999. PMID: 10070819 Review. No abstract available.

6

[Antithrombotics and interventional cardiology].

Collet JP, Montalescot G. Collet JP, et al. Among authors: montalescot g. Arch Mal Coeur Vaiss. 1999 Nov;92(11 Suppl):1667-79. Arch Mal Coeur Vaiss. 1999. PMID: 10598250 Review. French.

7

Low molecular weight heparin after mechanical heart valve replacement.

Montalescot G, Polle V, Collet JP, Leprince P, Bellanger A, Gandjbakhch I, Thomas D. Montalescot G, et al. Circulation. 2000 Mar 14;101(10):1083-6. doi: 10.1161/01.cir.101.10.1083. Circulation. 2000. PMID: 10715251 Clinical Trial.

8

Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy.

Collet JP, Park D, Lesty C, Soria J, Soria C, Montalescot G, Weisel JW. Collet JP, et al. Among authors: montalescot g. Arterioscler Thromb Vasc Biol. 2000 May;20(5):1354-61. doi: 10.1161/01.atv.20.5.1354. Arterioscler Thromb Vasc Biol. 2000. PMID: 10807754

9

Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina.

Montalescot G, Collet JP, Lison L, Choussat R, Ankri A, Vicaut E, Perlemuter K, Philippe F, Drobinski G, Thomas D. Montalescot G, et al. J Am Coll Cardiol. 2000 Jul;36(1):110-4. doi: 10.1016/s0735-1097(00)00695-1. J Am Coll Cardiol. 2000. PMID: 10898421 Free article. Clinical Trial.

10

Effect of prior exposure to Chlamydia pneumoniae, Helicobacter pylori, or cytomegalovirus on the degree of inflammation and one-year prognosis of patients with unstable angina pectoris or non-Q-wave acute myocardial infarction.

Choussat R, Montalescot G, Collet J, Jardel C, Ankri A, Fillet A, Thomas D, Raymond J, Bastard J, Drobinski G, Orfila J, Agut H, Thomas D. Choussat R, et al. Among authors: montalescot g. Am J Cardiol. 2000 Aug 15;86(4):379-84. doi: 10.1016/s0002-9149(00)00950-4. Am J Cardiol. 2000. PMID: 10946028

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

784 results

Search Page